The steady seven

Jim Collins's and Morten T. Hansen's "10X" companies outperformed their industries by a wide margin. Here's how they did it.

Amgen CEO Kevin Sharer
Not the most innovative biotech firm, but combination of creativity and discipline led it to outperform its industry from 1980 to 2002.

By Geoff Colvin, senior-editor-at-large - Last updated September 30 2011: 5:27 AM ET
Join the Conversation
How to manage through chaos

It's one thing to rise to greatness. It's another to do so in a time of upheaval, disruption, and economic turmoil (hello, 2011). How do some companies do it? Management guru Jim Collins shares the answers for the first time.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.